Tea and Depression: What Research Shows and What It Cannot Prove
Author: Ukrainian Psychological Hub · Published: September 29, 2026 · Editorial Policy
Research on tea and depression is interesting, inconsistent, and much easier to overstate than the evidence allows. Some observational studies report that people who drink more tea, especially green tea, have fewer depressive symptoms or a lower observed risk of depression. Other prospective studies find no clear association, and a 2024 Mendelian-randomization study reported a small association in the opposite direction. Randomized trials of green tea, extracts, L-theanine, and related compounds are heterogeneous and do not establish brewed tea as a treatment for major depressive disorder. The practical conclusion is therefore precise: tea can be an ordinary part of daily life, but current evidence does not show that drinking tea prevents, treats, or cures clinical depression.
This distinction matters because depression is not the same thing as feeling sad, tired, stressed, or temporarily low. Major depression is a clinical disorder defined by a pattern of symptoms, duration, and impairment. A cup of tea may change alertness, comfort, routine, or subjective mood in the short term without changing the course of a depressive disorder.
Tea itself is also not one exposure. True tea from Camellia sinensis contains caffeine, L-theanine, polyphenols, aroma compounds, and other constituents in amounts that vary by tea and preparation. Brewed green tea, black tea, matcha, decaffeinated tea, isolated caffeine, purified L-theanine, green-tea extract, EGCG supplements, and laboratory preparations should not be treated as interchangeable.
The Short Answer: What the Evidence Supports
Established: observational research has repeatedly found associations between higher tea or green-tea consumption and fewer depressive symptoms in some populations. Association does not establish that tea caused the difference.
Established: the observational literature is inconsistent. Meta-analyses and large cohorts do not all point in the same direction, and results depend on study design, population, tea definition, outcome measure, and statistical adjustment.
Preliminary: randomized trials involving green tea, matcha, extracts, L-theanine, EGCG, or combinations of tea compounds report some improvements in mood-related outcomes, but the interventions and populations are too heterogeneous to conclude that ordinary brewed tea treats clinical depression.
Established boundary: evidence from isolated L-theanine, caffeine, catechin extracts, or supplements cannot automatically be transferred to a cup of tea.
Established: caffeine can affect alertness, sleep, jitteriness, and anxiety-like feelings. These symptom-level effects can matter to someone with depression, yet they are not evidence of an antidepressant effect.
Plausible interpretation: tea rituals, warmth, sensory pleasure, regular breaks, expectation, and social routines can influence moment-to-moment experience and behavior. They remain contextual mechanisms rather than established treatments for depressive disorders.
If your question is simply “Does tea help depression?”, the evidence-based answer is: it may be associated with better mood or fewer depressive symptoms in some studies, but research has not proved that tea is an antidepressant treatment.
Depressive Mood, Depressive Symptoms, and Clinical Depression Are Different Outcomes
Tea studies often use the word “depression” for outcomes that are not identical. Some studies measure a score on a symptom questionnaire. Others identify people above a screening cutoff. Some ask whether a participant has ever received a diagnosis. Clinical trials may enroll people with a diagnosed major depressive disorder, while many tea studies enroll healthy adults and measure transient mood after a single dose.
According to the National Institute of Mental Health, major depression involves symptoms such as depressed mood or loss of interest that occur most of the day, nearly every day, for at least two weeks, together with other symptoms and clinically meaningful distress or impairment. Diagnosis requires clinical assessment; a beverage study, a mood score, or a self-report screening scale is not equivalent to a diagnosis.
This creates an important evidence hierarchy. A study showing that tea drinkers have a lower average depression-screening score supports an association with depressive symptoms. It does not demonstrate prevention of major depressive disorder. An acute trial showing a small improvement in “overall mood” after caffeine plus L-theanine does not demonstrate treatment of depression. A supplement trial in diagnosed patients is clinically more relevant, but it still does not establish that brewed tea produces the same effect.
What Observational Studies Have Found
Most of the apparent protective signal around tea and depression comes from observational research. These studies are useful because they can include large populations and habitual consumption over months or years. Their central limitation is equally important: tea drinkers and non-tea drinkers can differ in many other ways.
Earlier meta-analyses found lower observed depression risk among tea drinkers
A 2015 meta-analysis by Dong and colleagues combined 11 observational studies with 22,817 participants and reported a pooled relative risk of 0.69 for higher versus lower tea consumption. The authors also reported an inverse dose-response pattern. Those numbers are often repeated as if they show that tea prevents depression. They do not. The pooled estimate summarizes nonrandomized associations, so residual confounding, reverse causation, measurement differences, and cultural or lifestyle patterns remain possible explanations.
A 2016 systematic review and dose-response meta-analysis by Grosso and colleagues reached a more cautious result. Across observational datasets, tea showed a borderline, statistically nonsignificant association with depression risk: pooled relative risk 0.70 with a 95% confidence interval from 0.48 to 1.01. In the same paper, evidence for coffee and caffeine looked different from the evidence for tea. That alone is a warning against collapsing “caffeinated beverages” into one exposure.
Green-tea studies often look favorable, but most are cross-sectional
A 2022 systematic review and meta-analysis focused on green tea found eight eligible studies. Higher green-tea consumption was associated with fewer depressive symptoms overall, with a pooled odds ratio of 0.66. The design breakdown is the crucial detail: seven of the eight studies were cross-sectional. The single cohort estimate was imprecise and not statistically significant. Cross-sectional studies measure exposure and outcome around the same period, making temporal direction especially hard to establish.
There are several ways reverse causation could work. People with emerging depression may change appetite, routines, social activity, caffeine use, or willingness to prepare tea. Conversely, people with stable routines, healthier diets, stronger social networks, or particular cultural habits may drink more tea and also differ in depression risk for reasons that are only partly measured.
Prospective cohorts still disagree
Prospective cohorts improve temporal ordering because tea intake is measured before later depressive symptoms. They still remain observational.
A 2022 Chinese cohort study followed 7,524 adults who were free of depressive symptoms at baseline. Over a median of two years, the highest green-tea intake category had a lower adjusted hazard of developing depressive symptoms than the reference category. This supports a possible longitudinal association, but it remains a population-specific observational result and does not identify the causal ingredient or mechanism.
A much larger 2024 five-year Japanese cohort study evaluated 94,873 adults at baseline, with 80,497 completing depression follow-up. After full adjustment, the green-tea result did not reach statistical significance. This modern null result is important because it shows that an inverse association is not inevitable even in a large population where green tea is common.
The contrast between cohorts is scientifically more informative than choosing the study with the most appealing result. Differences can arise from baseline age, amount and type of tea, dietary context, depression measurement, follow-up length, socioeconomic variables, smoking and alcohol patterns, physical activity, comorbidity, and how statistical models handle those factors.
A 2023 meta-analysis found no clear tea dose-response
A 2023 systematic review and dose-response meta-analysis included 29 observational studies with 422,586 participants across coffee, caffeine, and tea exposures. Its abstract concluded that the evidence did not show a link between tea consumption and reduced depressive symptoms and called for more longitudinal research. In the full analysis, some high-versus-low tea comparisons were inverse, but a clear dose-response relationship was not demonstrated. This is exactly the kind of mixed pattern that should be described as uncertain rather than simplified into “tea lowers depression risk.”
Mendelian randomization produced a small association in the opposite direction
A 2024 two-sample Mendelian-randomization study used genetic variants associated with tea intake as instrumental variables and reported that genetically predicted higher tea intake was associated with a slightly higher odds of depression: OR 1.029, 95% CI 1.003–1.055. Bayesian weighted analysis produced a similar estimate.
Mendelian randomization can reduce some forms of confounding and reverse causation, but it has its own assumptions. Genetic instruments must influence the outcome through the exposure pathway being modeled, must be sufficiently strong, and must not introduce relevant pleiotropic pathways. The exposure “tea intake” in a genetic dataset also does not encode a specific brewed tea, caffeine dose, preparation, cultural context, or lifetime behavioral pattern with perfect precision.
The MR result therefore matters because it conflicts with a simple protective narrative. It does not establish that drinking more tea causes depression. The appropriate synthesis is that current causal evidence is unsettled.
What Randomized Trials Show — and Why They Still Do Not Prove Tea Treats Depression
Randomized controlled trials can answer causal questions more directly, but only for the intervention, dose, population, comparator, duration, and outcome actually tested. Tea research frequently loses this specificity when findings from capsules or extracts are translated into claims about beverages.
A 2025 review found signals across heterogeneous green-tea interventions
A 2025 systematic review of randomized controlled trials identified 13 studies evaluating green tea, green-tea extract, matcha, L-theanine, or EGCG in relation to mood-related symptoms and brain-derived neurotrophic factor. Seven studies used isolated bioactive compounds, while six used green-tea extract, matcha, or traditional green tea. Some studies reported improvements in depressive, anxiety, stress, or sleep symptoms, while no included study found a statistically significant effect on BDNF.
That review is useful evidence of a research signal. It is not a trial of “tea for depression.” Combining different interventions and outcomes cannot tell a reader that a particular number of cups of green tea will improve diagnosed major depression. It also cannot erase differences between an extract dose, a matcha preparation, an L-theanine capsule, and ordinary brewed tea.
A broader 2025 meta-analysis mostly informs acute mood and cognition in healthy people
A separate 2025 systematic review and meta-analysis by Payne and colleagues included 50 randomized trials of tea, L-theanine, or L-theanine plus caffeine in healthy participants; 15 trials contributed to at least one meta-analysis. The review found small-to-moderate differences on selected cognition and mood outcomes, particularly for L-theanine plus caffeine, while confidence intervals often showed uncertainty. The authors specifically called for more research using tea beverages, tea-equivalent doses, and free-living participants.
The population boundary is decisive: healthy participants completing attention or mood tasks are not the same population as people with major depressive disorder. A short-term change in alertness, reaction time, fatigue, or “overall mood” should not be relabeled as an antidepressant effect.
The L-theanine plus sertraline trial is clinically relevant but not evidence for brewed tea
One 2023 randomized double-blind placebo-controlled trial enrolled 60 people with DSM-5 major depressive disorder. Participants received sertraline plus either 200 mg/day of isolated L-theanine or placebo for six weeks; 50 completed the study. The L-theanine group showed greater improvement on the Hamilton Depression Rating Scale, and the authors called for larger, longer trials.
This result is worth knowing because it involved diagnosed depression. It is also a textbook example of why exposure boundaries matter. The intervention was 200 mg/day of isolated L-theanine added to an antidepressant, not brewed tea used alone. The study was small and short. It cannot support the claim that green tea, matcha, or any other tea replaces sertraline, psychotherapy, or another evidence-based treatment.
Tea Beverage Evidence vs Caffeine, L-Theanine, Extracts, and Supplements
The strongest way to avoid misleading conclusions is to keep each exposure in its own lane.
Brewed tea: a complex beverage whose caffeine, L-theanine, polyphenols, aroma, temperature, serving size, and preparation vary. Epidemiological studies often measure cups or frequency rather than chemical dose.
Matcha: powdered green tea in which suspended leaf material is consumed. It is still a beverage, but its dose profile differs from steeped green tea and can be more concentrated.
Isolated caffeine: a stimulant with well-characterized acute effects on alertness and sleep. A caffeine capsule is not equivalent to tea.
Isolated L-theanine: a purified amino acid used at controlled doses in experimental and supplement studies. A 200 mg capsule cannot be assumed to equal an ordinary cup of tea.
Green-tea extract or EGCG supplement: concentrated preparations that may deliver constituent doses unlike customary beverage intake. Evidence and safety considerations for extracts should not be generalized to brewed tea.
When a study tests one of these exposures, the claim should stay attached to that exposure. This matters especially in mental-health content, where a seemingly small wording shift can turn preliminary compound research into an unsupported treatment recommendation.
Caffeine: The Most Immediate Way Tea Can Affect How Someone Feels
Caffeine is the component of tea most likely to produce a noticeable short-term change. It can increase alertness and reduce sleepiness, and people vary greatly in sensitivity. The FDA notes that for most adults 400 mg of caffeine per day is an amount not generally associated with negative effects, while also emphasizing wide individual variation and symptoms such as insomnia, anxiety, jitteriness, palpitations, nausea, and headache when intake is too high for a particular person.
Tea usually contains less caffeine per standard serving than brewed coffee, but the amount varies substantially by product and preparation. For practical caffeine comparisons across black, green, matcha, oolong, white, herbal, and decaf tea, see Caffeine in Tea.
Alertness is not antidepressant efficacy
Someone with depression may experience fatigue, slowed thinking, or difficulty concentrating. Caffeine can temporarily increase wakefulness and alertness, so a caffeinated tea may feel helpful in the moment. That subjective benefit is real as an experience. It does not demonstrate that caffeine treats the underlying depressive disorder.
Habitual caffeine use also introduces tolerance and withdrawal. A morning drink can feel as though it is restoring mood or energy partly because it relieves withdrawal after overnight abstinence. This is another reason not to interpret every immediate improvement after tea as evidence of a disease-modifying effect.
Sleep can turn a helpful-feeling drink into an unhelpful pattern
Sleep and depression are tightly connected clinically, and caffeine can interfere with sleep. A 2023 systematic review and meta-analysis of 24 caffeine studies found reduced total sleep time and sleep efficiency, longer sleep-onset latency, and changes in sleep architecture after caffeine. The studies involved caffeine from different sources and doses, so their timing estimates should not be converted into one universal cutoff for tea.
For a person who is sensitive to caffeine or already struggling with insomnia, late-day caffeinated tea can worsen a symptom that matters greatly to well-being. For someone who tolerates an earlier cup without sleep disruption, the same concern may be much smaller. Individual response, dose, timing, and total caffeine from all sources matter more than the idea that tea is inherently “calming.”
Jitteriness and anxiety-like effects can complicate mood
Caffeine can also increase restlessness and anxiety-like feelings. A 2024 meta-analysis of caffeine and anxiety included 546 healthy participants and found higher anxiety outcomes after caffeine, with larger effects at higher doses. The evidence concerns caffeine, often at doses higher than those in a single ordinary cup of tea, and it does not diagnose an anxiety disorder.
For someone with depression who also experiences panic, agitation, palpitations, or pronounced caffeine sensitivity, reducing caffeine may improve comfort or sleep even though it is not an antidepressant treatment. The distinction is practical: modifying a trigger can improve a symptom without treating the full disorder.
L-Theanine: Interesting Evidence, Frequent Overreach
L-theanine is naturally present in tea and is especially associated in popular wellness writing with “calm focus.” Controlled studies make the topic more interesting than pure marketing, but they also show why precision is necessary.
The 2025 randomized-trial meta-analysis described above found selected cognitive and mood benefits from L-theanine alone or L-theanine combined with caffeine in healthy participants, with uncertainty across outcomes. The small sertraline-adjunct trial found improved depression scores with 200 mg/day of isolated L-theanine. Neither result tells us that a cup of green tea delivers an equivalent dose, blood concentration, or clinical effect.
Tea chemistry varies by cultivar, growing conditions, processing, leaf dose, and brewing. Even if a cup contains both caffeine and L-theanine, the ratio is not standardized like a laboratory intervention. “Tea contains L-theanine” is chemically true. “Therefore tea treats depression” is an evidentiary leap.
Polyphenols, EGCG, Inflammation, the Gut–Brain Axis, and BDNF
Tea polyphenols, including catechins such as EGCG, are frequently proposed as mechanisms linking tea with brain health. Preclinical studies have investigated oxidative stress, inflammatory signaling, neurotransmission, neuroplasticity, the gut microbiome, and brain-derived neurotrophic factor. These are legitimate research areas, but mechanistic plausibility and clinical efficacy are different questions.
The 2025 randomized-trial review of green tea and its compounds found no statistically significant effect on BDNF in the included studies. That does not prove BDNF is irrelevant; it shows that a popular mechanistic story has not translated into a clear human trial signal in that evidence set.
Animal and cell experiments are valuable for generating hypotheses and identifying biological pathways. They cannot establish that drinking tea prevents or treats human depression. Claims about inflammation, dopamine, serotonin, cortisol, BDNF, or the gut–brain axis should therefore be presented as mechanistic research unless clinical outcomes in humans support the stronger statement.
Why Tea Drinkers Might Look Less Depressed Even If Tea Is Not the Cause
Observational associations can arise from the beverage, the person who chooses it, the environment in which it is consumed, or combinations of all three. Several pathways are plausible.
Diet and health behavior
Tea drinking can correlate with diet quality, smoking, alcohol use, physical activity, sleep schedules, health consciousness, and other behaviors. Statistical models adjust for some of these variables, but measurement is imperfect and unmeasured confounding remains possible.
Socioeconomic and cultural context
The meaning of tea differs across countries, age groups, households, and social settings. A “cup of tea” can represent a solitary caffeinated drink, a family routine, workplace hospitality, a formal ritual, or a marker of broader dietary patterns. A result from older Japanese adults, Chinese workers, or a Western cohort cannot automatically be treated as a universal biological effect.
Reverse causation
Depressive symptoms can change appetite, motivation, daily structure, social contact, and stimulant use. If depression changes tea consumption, then an observed tea–depression association may partly reflect the outcome influencing the exposure rather than the reverse.
Healthy-user and routine effects
People who maintain regular meals, hydration, morning routines, social contact, or restorative breaks may also maintain a tea habit. The tea can be part of that pattern without being the sole active cause.
The Psychological Layer: Ritual, Expectation, Attention, and Comfort
Tea can have psychological value even when it is not a treatment for depression. A warm drink creates a sensory event: aroma, temperature, taste, hand-to-cup contact, a familiar vessel, and a short interruption in ongoing activity. Repetition can turn those cues into a learned routine.
Expectation also shapes experience. If a person associates a particular tea with waking up, reading, working, visiting family, or winding down, the drink can become a cue for attention or comfort. Social tea drinking can provide a reason to sit with another person. Preparing tea can impose a small sequence of actions on a day that otherwise feels unstructured.
These effects are psychologically meaningful because depression often affects motivation, pleasure, concentration, sleep, and social behavior. Yet the correct claim remains modest: a ritual may support routine, sensory engagement, or social connection. Research has not shown that the ritual itself is a stand-alone treatment for major depressive disorder.
The distinction also protects against a common mistake in wellness culture: turning an ordinary comfort into a medical promise. A person can legitimately say, “Tea helps me feel more settled in the afternoon,” without that statement becoming “tea treats my depression.”
Is Green Tea Better Than Black Tea for Depression?
There is not enough clinical evidence to rank tea types as antidepressant choices. Green tea appears more often in the depression literature, particularly in East Asian observational studies and in research on catechins and L-theanine. Greater research volume does not equal proven superiority.
Black tea contains caffeine, L-theanine, and polyphenol-derived compounds with a different chemical profile after oxidation. It has not been shown in high-quality clinical trials to treat depression. Matcha is often marketed for mood and focus because the powdered leaf delivers concentrated tea material, but there is no established matcha dose for depression treatment.
A “best tea for depression” ranking would therefore manufacture certainty that the research does not contain. The more useful question is which tea fits a person's taste, caffeine sensitivity, sleep needs, medications, and daily routine without being mistaken for therapy.
What About Chamomile, Rooibos, and Other Herbal Teas?
Herbal teas are not Camellia sinensis tea, and evidence for one plant cannot be transferred to another. Chamomile, rooibos, peppermint, lavender, lemon balm, and other infusions have different constituents and different research literatures. A caffeine-free infusion may be useful for someone who wants a warm evening drink without caffeine, but that practical role is not proof of an antidepressant effect.
The NIMH notes that the FDA has not approved natural products for treating depression and that evidence for natural products can be inconsistent. Some supplements can also interact with medications. This is particularly important when “tea” language blurs into concentrated herbal products or supplements.
Can Tea Make Depression Worse?
There is no strong evidence that ordinary tea consumption universally worsens depression. The question becomes more useful when broken into specific pathways.
Caffeine sensitivity: tea can produce jitteriness, palpitations, restlessness, or anxiety-like feelings in sensitive people.
Sleep disruption: late or high caffeine intake can impair sleep, which may worsen daytime fatigue, concentration, irritability, and emotional regulation.
Appetite and routine: using caffeinated drinks in place of regular meals or relying on them to push through exhaustion can create an unhelpful pattern even if the tea itself is not the primary problem.
Medication and health context: caffeine sensitivity can vary with medications and medical conditions. A clinician or pharmacist is the right source for individualized interaction questions.
Withdrawal: abruptly reducing habitual caffeine can cause headache, fatigue, irritability, and low mood, which can be confused with a change in the underlying disorder.
For most adults, the FDA cites 400 mg/day as an amount not generally associated with negative effects, but that is a population-level reference rather than a personal target. Someone who develops insomnia or marked jitteriness at much lower intake has useful information about their own sensitivity.
A Practical Way to Use Tea When You Have Depression
Tea does not need a medical claim to have a place in someone's day. A practical approach is to treat it as a beverage and routine, then adjust it around symptoms and treatment rather than treating it as treatment.
Keep evidence-based depression care separate from beverage choices. Do not stop or replace medication, psychotherapy, or another prescribed treatment because of claims about tea, matcha, L-theanine, or green-tea extract.
Notice caffeine rather than assuming every tea is calming. Track whether caffeinated tea affects sleep, agitation, palpitations, or anxiety-like feelings.
Move caffeine earlier if sleep seems sensitive. There is no single universal cutoff because dose, metabolism, bedtime, and total daily intake differ.
Choose decaf or a genuinely caffeine-free infusion when the ritual matters more than stimulation.
Avoid translating supplement studies into beverage doses. A capsule containing 200 mg of L-theanine is not a recipe for cups of green tea.
Use tea as one small routine if it is enjoyable: preparation, hydration, a break, or a social cue can have everyday psychological value without becoming a medical intervention.
When Low Mood Needs More Than a Beverage
Occasional sadness, stress, or fatigue is common. Persistent depression is different. If low mood, loss of interest, sleep or appetite changes, guilt, hopelessness, impaired concentration, or loss of functioning persists, a health professional can assess what is happening and discuss evidence-based options.
NIMH guidance describes psychotherapy and medication as standard treatments for depression, with additional options for some people when those approaches are not sufficient. Tea can coexist with treatment when appropriate; it should not be used as a reason to delay assessment.
If you are in immediate danger, having thoughts of suicide, or feel unable to keep yourself safe, seek urgent help through your local emergency service or crisis service now.
How to Read Tea-and-Depression Headlines Without Being Misled
A useful headline test is to ask five questions.
Was the study observational or randomized? “Tea drinkers had lower depression scores” is not the same as “tea reduced depression in a trial.”
What was actually consumed? Brewed tea, matcha, extract, caffeine, L-theanine, EGCG, and supplements are different exposures.
Who was studied? Healthy volunteers, people with depressive symptoms, and patients with diagnosed major depressive disorder are not interchangeable populations.
What outcome changed? Alertness, stress, a questionnaire score, remission, and diagnosed depression are different endpoints.
How long did the study last? A two-hour mood effect cannot answer a six-month clinical question.
When all five questions are answered, much of the apparent contradiction in tea research becomes understandable. Different studies are often answering different questions.
Frequently Asked Questions
Can tea help with depression?
Tea may provide comfort, alertness, routine, or social connection, and some observational studies associate higher tea intake with fewer depressive symptoms. Current research does not establish tea as a treatment for clinical depression.
Does green tea prevent depression?
No prevention claim is established. Several observational studies and a 2022 meta-analysis found inverse associations, but most of that evidence was cross-sectional, prospective cohorts are inconsistent, and causal evidence remains unsettled.
What is the best tea for depression?
Research does not support a scientifically defensible “best tea for depression.” Green tea is studied more often than many other teas, but evidence volume is not proof of clinical superiority.
Can caffeine in tea worsen how I feel?
Yes, in some people. Caffeine can contribute to insomnia, jitteriness, palpitations, or anxiety-like feelings. Those effects may worsen comfort, sleep, or daytime functioning even though they are not the same as worsening the underlying depressive disorder.
Is L-theanine an antidepressant?
L-theanine has preliminary clinical and experimental evidence, including a small trial as an adjunct to sertraline. That is not enough to classify ordinary tea or L-theanine as an established antidepressant treatment.
Can I drink tea while taking antidepressants?
Many people do, but interaction questions depend on the medication, dose, other ingredients, medical conditions, and total caffeine intake. Ask a pharmacist or prescriber about your specific medication rather than assuming all teas and herbal products are equivalent.
Can tea replace therapy or antidepressant medication?
No evidence supports replacing evidence-based depression treatment with tea. If tea is enjoyable and compatible with your health situation, it can be part of daily life alongside appropriate care.
Does decaf tea have the same depression evidence?
Not necessarily. Most epidemiological studies do not isolate decaffeinated tea well enough to answer that question, and removing most caffeine changes one of the beverage's active components. Decaf can still preserve the sensory and ritual aspects of tea.
Conclusion: Tea Is an Interesting Exposure, Not a Proven Depression Treatment
The tea-and-depression literature contains a real signal and real uncertainty. Earlier observational meta-analyses often found lower depressive symptoms among people who drank more tea or green tea. Later syntheses and large prospective cohorts have produced mixed or null findings, while a Mendelian-randomization analysis reported a small association in the opposite direction. Randomized trials of green tea and its compounds suggest possible mood-related effects, yet they mix beverages, extracts, matcha, purified L-theanine, EGCG, healthy participants, symptom scales, and clinical populations.
The evidence therefore supports investigation, not a treatment claim. Brewed tea can affect alertness, sleep, anxiety-like sensations, taste, comfort, routine, and social experience. Those effects can matter to a person living with depression. They do not establish that tea prevents, treats, or cures major depressive disorder.
For readers who want to understand the stimulant side of the question in detail, the next evidence node is Caffeine in Tea: Black, Green, Matcha, Oolong, White, and Herbal Tea Compared.
Related Articles
References
Cavanah, A. M., Robinson, L. A., Mattingly, M. L., & Frugé, A. D. (2025). The Impact of Green Tea and Its Bioactive Compounds on Mood Disorder Symptomology and Brain Derived Neurotrophic Factor: A Systematic Review of Randomized Controlled Trials. Biomedicines, 13(7), 1656. DOI: 10.3390/biomedicines13071656.
Dong, X., Gu, Y., Rayamajhi, S., et al. (2022). Green tea consumption and risk of depressive symptoms: Results from the TCLSIH Cohort Study. Journal of Affective Disorders, 310, 183–188. DOI: 10.1016/j.jad.2022.04.112.
Dong, X., Yang, C., Cao, S., et al. (2015). Tea consumption and the risk of depression: a meta-analysis of observational studies. Australian & New Zealand Journal of Psychiatry, 49(4), 334–345. DOI: 10.1177/0004867414567759.
Gardiner, C., Weakley, J., Burke, L. M., et al. (2023). The effect of caffeine on subsequent sleep: A systematic review and meta-analysis. Sleep Medicine Reviews, 69, 101764. DOI: 10.1016/j.smrv.2023.101764.
Grosso, G., Micek, A., Castellano, S., Pajak, A., & Galvano, F. (2016). Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies. Molecular Nutrition & Food Research, 60(1), 223–234. DOI: 10.1002/mnfr.201500620.
Liu, C., Wang, L., Zhang, C., et al. (2024). Caffeine intake and anxiety: a meta-analysis. Frontiers in Psychology, 15, 1270246. DOI: 10.3389/fpsyg.2024.1270246.
Narita, Z., Hidese, S., Kanehara, R., et al. (2024). Association of sugary drinks, carbonated beverages, vegetable and fruit juices, sweetened and black coffee, and green tea with subsequent depression: A five-year cohort study. Clinical Nutrition, 43(6), 1395–1404. DOI: 10.1016/j.clnu.2024.04.017.
National Institute of Mental Health. Depression. U.S. National Institutes of Health.
Shamabadi, A., Kafi, F., Arab Bafrani, M., et al. (2023). L-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial. Journal of Affective Disorders, 333, 38–43. DOI: 10.1016/j.jad.2023.04.029.
Torabynasab, K., Shahinfar, H., Payandeh, N., & Jazayeri, S. (2023). Association between dietary caffeine, coffee, and tea consumption and depressive symptoms in adults: A systematic review and dose-response meta-analysis of observational studies. Frontiers in Nutrition, 10, 1051444. DOI: 10.3389/fnut.2023.1051444.
Yaegashi, Y., et al. (2022). Green Tea Consumption and Risk of Depression Symptoms: A Systematic Review and Meta-Analysis of Observational Studies. Journal of Nutritional Science and Vitaminology, 68(3), 155–161. DOI: 10.3177/jnsv.68.155.
